These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 4805362)

  • 21. Investigation and appplication of the USSR AMS live measles vaccine from the ESC strain for mass vaccination against measles.
    Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):1-18. PubMed ID: 4985647
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical and serological studies on a further attenuated live measles virus AIK vaccine].
    Nino K
    Kansenshogaku Zasshi; 1973 Apr; 47(4):116-24. PubMed ID: 4199824
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dynamics of the serologic response of children vaccinated with live AMN USSR measles vaccine prepared from the ESzCz strain].
    Sinjak KM; Czumakow MP; Rodin WI; Czudnaja LM; Sziechtier AB; Winograd IA; Urin AI; Glinskaja LA; Szwiec LT; Knjaziewa II; Niemiec ZA
    Przegl Epidemiol; 1970; 24(1):15-20. PubMed ID: 5431385
    [No Abstract]   [Full Text] [Related]  

  • 24. [Experiences with the live measles virus vaccines L-4 and L-16 in the German Democratic Republic].
    Starke G
    Pathol Microbiol (Basel); 1965; 28(6):950-5. PubMed ID: 5879805
    [No Abstract]   [Full Text] [Related]  

  • 25. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparative value of 3 anti-measles vaccines with attenuated live virus. Immuno-epidemiological study].
    Topciu V; Arion R; Moldovan E; Csaky N; Olaru G
    Arch Roum Pathol Exp Microbiol; 1971 Mar; 30(1):119-27. PubMed ID: 5096857
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical reactogenicity and immunogenicity of five live measles vaccine strains.
    Chin Med J (Engl); 1981 Apr; 94(4):201-6. PubMed ID: 6790234
    [No Abstract]   [Full Text] [Related]  

  • 28. INACTIVATED MEASLES VIRUS VACCINE SUBSEQUENTLY CHALLENGED WITH LIVE ATTENUATED MEASLES VIRUS VACCINE.
    KIMURA M; ISHIGURO Y
    Jpn J Med Sci Biol; 1965 Feb; 18():65-71. PubMed ID: 14300296
    [No Abstract]   [Full Text] [Related]  

  • 29. [Time of the appearance of immunity to measles after the administration of a live measles vaccine].
    Revenok ND
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():355-60. PubMed ID: 5860953
    [No Abstract]   [Full Text] [Related]  

  • 30. [Measles immunization and its problems].
    Kökkaya A
    Mikrobiyol Bul; 1982 Jan; 16(1):66-70. PubMed ID: 7144618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on further attenuated live measles vaccine. IV. Clinical and serological evaluation of a clone of CAM-CEF measles vaccine virus.
    Ueda S; Takahashi M; Kurimura T; Ogino T; Suzuki N
    Biken J; 1970 Sep; 13(3):169-74. PubMed ID: 5530511
    [No Abstract]   [Full Text] [Related]  

  • 32. Mass measles vaccination: experience with live attenuated virus vaccine in and around Vellore.
    Benjamin V; Jadhav M; Roberts PO
    Indian Pediatr; 1969 Mar; 6(3):102-13. PubMed ID: 5784931
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical reactions and antibody responses of measles-susceptible healthy children to the live measles "AIK-C" vaccine(chick embryo tissue culture type)].
    Okayama T
    Kansenshogaku Zasshi; 1975 Apr; 49(4):150-8. PubMed ID: 811729
    [No Abstract]   [Full Text] [Related]  

  • 34. [Specific anti-measles prophylaxis in Rumania. 3. Comparative study of some live attenuated virus vaccines].
    Cajal N; Cepleanu M; Cernescu C; Sorodoc Y
    Stud Cercet Inframicrobiol; 1969; 20(4):275-85. PubMed ID: 5371258
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effectiveness of mumps virus given alone or in combination with live vaccines against measles and rubella.
    Nasibov MN; Yakovleva NV; Smorodintsev AA
    Prog Immunobiol Stand; 1970; 4():676-82. PubMed ID: 5482205
    [No Abstract]   [Full Text] [Related]  

  • 37. Vaccination against measles. Clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Third report to the Medical Research Council by the Measles Vaccines Committee.
    Practitioner; 1971 Apr; 206(234):458-66. PubMed ID: 4930718
    [No Abstract]   [Full Text] [Related]  

  • 38. [Anti-measles vaccination with inactivated virus].
    Terragna A; Roscioli B; De Marco B
    G Mal Infett Parassit; 1967 Apr; 19(4):219-22. PubMed ID: 5614197
    [No Abstract]   [Full Text] [Related]  

  • 39. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 40. [Development and evolution of an antimeasles vaccine].
    Weibel RE
    Bol Oficina Sanit Panam; 1974 Aug; 77(2):135-40. PubMed ID: 4277803
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.